$15.99 $0.26 per serving
Product analysis
Co-Q10 100 mg supports normal cellular energy production and may offer limited support for blood-vessel function. Expected benefits depend on the preparation and the people taking it.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The ubiquinone form is clearly identified, but its quality relative to other CoQ10 preparations cannot be confirmed. The name alone does not establish a health advantage.
Ingredient Transparency100
The CoQ10 amount and form are stated. That makes the serving easy to compare with other CoQ10 supplements.
Value For Money60
The serving offers moderate value for CoQ10. Whether it is useful depends on the intended purpose and preparation.
Customer Satisfaction89
Customer feedback is very positive across a substantial number of ratings. The review volume supports broad satisfaction without proving cardiovascular or energy benefits.
Product Focus70
CoQ10 has limited support for blood-vessel function and certain heart-related measures in selected groups. Routine energy benefits remain uncertain, and the serving does not automatically match the repeated use behind those findings.
- Format
Capsule - Container
- 60 Veggie Cap(s)
- Per serving
- $0.26
- Also available
Co-Q10 200 mg$25.99- Customer rating
- 4.8 · 2,732 ratings
Goals
Impact
Highest effect
Coenzyme Q-10 · 100 mg
CoQ10 has limited evidence for effects on vascular function, blood pressure and lipid markers in selected groups. The 100 mg ubiquinone serving receives partial amount recognition for its preparation. Those findings do not establish routine prevention of heart attacks or strokes, and heart-failure treatment results do not automatically apply to general supplement use. One serving also does not establish the repeated exposure used in studies.
How this product is rated for Heart Health
Ingredient fit86
CoQ10 account for the relevant ingredient findings. Their amounts receive partial comparison recognition overall.
Goal fit
CoQ10 provide the relevant connections; the saved focus also reflects other ingredients and linked uses.
Dose adequacy
Amount recognition is partial overall, reflecting the supplied quantities and preparation-specific comparisons.
Pathways53
The strongest saved connection is endothelial nitric-oxide function. Coverage reaches the threshold in one pathway.
Depth
The strongest saved contribution concerns endothelial nitric-oxide function; this mechanism or marker does not itself establish prevention of cardiovascular events.
Breadth
Only endothelial nitric-oxide function reached the tracked coverage threshold.
Evidence98
CoQ10 leads the recognised evidence contribution. The included preparations receive recognition, subject to the specific clinical limitations.
Evidence strength
CoQ10 provides the strongest recognised evidence contribution, with the population and outcome limitations described for that ingredient.
Studied preparation
The included preparations receive recognition in the saved comparison, without establishing broader preventive effects.
Formulation logic100
Included ingredients meet the saved amount threshold and lack no required partners. No configured conflict was identified.
Partner coverage
No required partner is missing for the included ingredients.
Conflicts
No configured conflict was identified in the supplied facts.
Effective doses
All included ingredients reach the saved amount threshold; this is a comparison threshold rather than a proven clinically effective dose.
Impact
High effect
Coenzyme Q-10 · 100 mg
CoQ10 participates in mitochondrial energy production, and this product identifies the ubiquinone form. The supplied evidence supports only limited, preparation-specific fatigue relief; results in clinical disease groups do not establish a routine energy increase in healthy adults. The 100 mg serving makes a partial amount contribution in the saved findings.
How this product is rated for Energy
Ingredient fit73
The 100 mg ubiquinone serving contributes partially against the supplied amount reference.
Goal fit
CoQ10 keeps the counted formula focused, while its links to other goals limit how specifically it targets energy.
Dose adequacy
The 100 mg ubiquinone serving contributes partially against the supplied amount reference.
Pathways17
The main contribution is concentrated in mitochondrial energy production, with partial coverage rather than demonstrated improvement across all forms of fatigue.
Depth
The main contribution is concentrated in mitochondrial energy production, with partial coverage rather than demonstrated improvement across all forms of fatigue.
Breadth
No named energy category reaches the saved breadth threshold.
Evidence84
CoQ10 supplies the evidence contribution, with limited preparation-specific fatigue findings and restricted transfer from clinical populations.
Evidence strength
CoQ10 supplies the evidence contribution, with limited preparation-specific fatigue findings and restricted transfer from clinical populations.
Studied preparation
Ubiquinone is explicitly identified; no absorption-superiority advantage is established.
Formulation logic100
The counted ingredients have no missing partner requirement or identified conflict. Their amounts meet the saved minimum counting criterion.
Partner coverage
The counted ingredients have no unmet partner requirement in the supplied findings.
Conflicts
No matched ingredient conflict was identified in the supplied findings.
Effective doses
All counted ingredients reach the saved minimum amount criterion; this is not a proven threshold for fatigue relief.
Impact
High effect
Coenzyme Q-10 · 100 mg
Coenzyme Q10 helps mitochondria transfer energy as part of normal cell function. That role does not establish that this serving raises whole-body energy expenditure. The supplied metabolic-control findings concern a different outcome, and neither a durable fat-loss effect nor an advantage of a particular CoQ10 form is established.
How this product is rated for Metabolism Support
Ingredient fit73
Coenzyme Q-10 supplies the product's counted contribution, with partial amount allowance in the saved comparison.
Goal fit
Coenzyme Q-10 is the sole credited ingredient; the product is also linked to other goals.
Dose adequacy
Declared amounts receive partial allowance against the comparison amounts; this does not identify a proven effective dose.
Pathways17
The saved findings mainly concern mitochondrial energy and fat oxidation, with limited breadth across other routes.
Depth
The strongest represented route is mitochondrial energy and fat oxidation; this describes the saved ingredient mapping, not a measured rise in energy expenditure.
Breadth
No route reaches the comparison's coverage threshold.
Evidence75
The retained findings must be interpreted alongside the distinction between ordinary metabolic roles and a demonstrated increase in energy expenditure.
Evidence strength
CoQ10's mitochondrial role does not establish increased whole-body energy expenditure.
Studied preparation
The saved findings accept the counted preparations; this does not establish that this exact product or combination increased energy expenditure.
Formulation logic100
The retained ingredients meet the amount check and have no missing required partners. No evaluated ingredient conflict was triggered.
Partner coverage
No required partner is missing among the counted ingredients; this does not establish extra benefit from combining them.
Conflicts
None of the evaluated ingredient conflicts was triggered.
Effective doses
All ingredients retained for this check meet its amount threshold; the threshold is not a proven clinical minimum.
Impact
Moderate effect
Coenzyme Q-10 · 100 mg
CoQ10 at 100 mg relates to mitochondrial energy production and antioxidant defence. The supplied human evidence concerns limited skin-appearance outcomes with a particular preparation; the saved assessment does not match this preparation to those trials.
How this product is rated for Longevity
Ingredient fit73
The assessed ingredient is closely focused on the goal, although it is also linked to other uses. The assessed amounts provide partial dose support.
Goal fit
The assessed ingredient is closely focused on the goal, although it is also linked to other uses.
Dose adequacy
The assessed amounts provide partial dose support.
Pathways10
The strongest assessed connection is mitochondrial energy production, with limited coverage. No assessed pathway reaches the saved threshold for substantial coverage.
Depth
The strongest assessed connection is mitochondrial energy production, with limited coverage.
Breadth
No assessed pathway reaches the saved threshold for substantial coverage.
Evidence30
Coenzyme Q-10 provides the strongest effective-dose evidence in the saved findings; this does not translate into a lifespan benefit. The assessed preparation is not matched to the reviewed trials in the saved findings.
Evidence strength
Coenzyme Q-10 provides the strongest effective-dose evidence in the saved findings; this does not translate into a lifespan benefit.
Studied preparation
The assessed preparation is not matched to the reviewed trials in the saved findings.
Formulation logic100
The assessed ingredients can contribute alone or have their required partner. No configured ingredient conflict was identified. 1 of 1 assessed ingredients reach the saved minimum dose threshold.
Partner coverage
The assessed ingredients can contribute alone or have their required partner.
Conflicts
No configured ingredient conflict was identified.
Effective doses
1 of 1 assessed ingredients reach the saved minimum dose threshold.
Impact
Highest effect
Coenzyme Q-10 · 100 mg
Coenzyme Q10 has limited evidence for changes in blood pressure, lipids and blood-vessel lining function in adults with dyslipidemia. The declared amount receives recognition, but preparation and population distinctions limit transfer to routine use. These marker findings do not establish fewer cardiovascular events, relief of statin symptoms or superiority of a particular form.
How this product is rated for Cardiovascular Support
Ingredient fit86
The formula contains ingredients relevant to skin nutrition. Their amounts and the presence of other actives determine how focused this finding is.
Goal fit
The relevant ingredients dominate the formula, although the product may also be linked to other goals.
Dose adequacy
The disclosed amounts provide partial support; smaller or unresolved quantities limit the amount finding.
Pathways53
The strongest recorded coverage concerns endothelial nitric-oxide function; this is a mechanism finding, not proof of fewer cardiovascular events.
Depth
The strongest recorded coverage concerns endothelial nitric-oxide function; this is a mechanism finding, not proof of fewer cardiovascular events.
Breadth
One cardiovascular mechanism reaches the coverage threshold, with limited coverage of the others.
Evidence88
Coenzyme Q-10 provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Evidence strength
Coenzyme Q-10 provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Studied preparation
The saved result accepts the relevant preparations, although this does not establish that the finished product matches a skin trial.
Formulation logic100
The included ingredients have no recorded missing partners or configured conflicts. Amount limitations are retained separately.
Partner coverage
No missing required ingredient partner limits the saved finding; this does not establish an added combination benefit.
Conflicts
No configured ingredient conflict was identified in the supplied evaluation.
Effective doses
All ingredients included in this finding meet the saved minimum amount threshold, without proving a clinical response.
Impact
High effect
Coenzyme Q-10 · 100 mg
Coenzyme Q10 has limited evidence for changing an inflammatory marker in statin-treated people with coronary disease. Other measured markers were unchanged, so a broad anti-inflammatory effect is not established. The ubiquinone comparison is accepted here, but the declared serving is not automatically the daily regimen used in that trial.
How this product is rated for Inflammation
Ingredient fit66
Coenzyme Q-10 is the relevant ingredient, with a declared amount for comparison.
Goal fit
The relevant ingredient declarations form a focused comparison for this goal, although clinical applicability remains limited.
Dose adequacy
Declared amounts only partly match the supplied comparisons; unresolved active quantities cannot establish adequacy.
Pathways13
The strongest assigned route concerns oxidative and mitochondrial stress; antioxidant activity alone does not establish clinical inflammation relief.
Depth
The strongest assigned route concerns oxidative and mitochondrial stress; antioxidant activity alone does not establish clinical inflammation relief.
Breadth
No assigned route reaches the supplied coverage criterion.
Evidence93
CoQ10 leads the saved evidence finding, based on limited biomarker results in statin-treated coronary disease.
Evidence strength
CoQ10 leads the saved evidence finding, based on limited biomarker results in statin-treated coronary disease.
Studied preparation
The supplied comparison accepts the relevant preparations; this does not establish equivalence of every formulation or a matching daily regimen.
Formulation logic100
No listed conflict or missing required partner is identified. Amount comparisons do not demonstrate an added benefit from combining ingredients.
Partner coverage
No required partner is missing among the recognized ingredients; this does not establish synergy.
Conflicts
No listed conflict is triggered by the supplied ingredient and amount facts.
Effective doses
All recognized ingredients meet the minimum amount comparison, which is not a proven biological threshold.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Coenzyme Q-10 (Ubiquinone) | 100 mg |
Coenzyme Q-10 (Ubiquinone) · 100 mg OverallScore59
Each serving provides 100 mg of ubiquinone, a form the body converts to ubiquinol. The assessment considers the amount suitable for general maintenance.
How this ingredient is rated
Active Ingredient Quality & Bioavailability48
The CoQ10 is ubiquinone, a form the body converts to ubiquinol. No qualifying advanced delivery feature or enhancer is recorded.
Molecular Form: Ubiquinol vs. Ubiquinone
The recorded form is ubiquinone, which the body converts to ubiquinol.
Formulation & Absorption Enhancers
No qualifying advanced delivery feature or black pepper enhancer is recorded in the saved facts.
Dose, Safety & Label Transparency71
The serving provides 100 mg of ubiquinone, with standard fillers recorded.
Clinical Dosage Alignment
Each serving provides 100 mg of ubiquinone, an amount the assessment considers suitable for general maintenance.
Label Transparency & Fillers
The CoQ10 amount is disclosed, and standard fillers are recorded.
Value60
The whole-product serving costs about $0.27 and provides 100 mg of CoQ10.
Price Per Effective Serving
The whole-product serving costs about $0.27 and provides 100 mg of CoQ10.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
- Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
- Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Antifatigue effects of coenzyme Q10 during physical fatigue.
- Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
- Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
- Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
- The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
- The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
- Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
- Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
- Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
- Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.